Table 2 Diagnostic criteria used in included studies to define ME/CFS (if reported)
Study | Diagnostic criteria used |
|---|---|
Antcliff et al. [25] | No diagnostic criteria included Participants had diagnosis of chronic low back pain, chronic widespread pain, fibromyalgia and ME/CFS for ≥ 3 months’ |
Antcliff et al. [63] | No diagnostic criteria included Participants had diagnosis of chronic low back pain, chronic widespread pain, fibromyalgia and ME/CFS for ≥ 3 months’ |
Antcliff et al. [50] | No diagnostic criteria included Participants had diagnosis of chronic low back pain, chronic widespread pain, fibromyalgia and ME/CFS for ≥ 3 months’ |
ME association. [55] | No diagnostic criteria included Survey open to anyone who had had ME, CFS, or post-viral fatigue syndrome |
Bourke et al. [61] | Oxford criteria (PACE trial sub-analysis) |
Brown et al. [54] | Fukuda criteria |
Brown et al. [60] | No diagnostic criteria included |
Dougall et al. [59] | Oxford criteria (PACE trial sub-analysis) |
Geraghty et al. [67] | No diagnostic criteria included Survey open to anyone who had ME/CFS. According to self-report, 72% received a diagnosis of by a specialist, 22% from a general practitioner (family doctor), and 4.5% from other professional |
Jason et al. [53] | Fukuda criteria |
Kos et al. [48] | Fukuda criteria |
Meeus et al. [49] | Fukuda criteria |
Nijs et al., 2009 [64] | Fukuda criteria |
O’Connor et al. [58] | Fukuda criteria |
Sharpe et al. [56] | Oxford criteria (PACE trial sub-analysis) |
White et al. [35] | Oxford criteria (PACE trial) |
White et al. [57] | Oxford criteria (PACE trial sub-analysis) |